Lewis v. Teva Pharmaceuticals USA, Inc. et al
Plaintiff: Lewis and Allison Lewis
Defendant: Teva Pharmaceuticals USA, Inc, Teva Pharmaceuticals USA, Inc., Teva Women's Health, LLC, Teva Women's Health, Inc. doing business as Teva Women's Health, LLC, The Cooper Companies, Inc., CooperSurgical, Inc., Teva Women's Health, LLC doing business as Teva Women's Health LLC, Teva Women's Health LLC and Teva Branded Pharmaceutical Products R&D, Inc.
Case Number: GAN/1:20-CV-03942
Filed: September 23, 2020
Court: Judicial Panel on Multidistrict Litigation
Presiding Judge: Leigh Martin May
Referring Judge: Eleanor L Ross
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on December 16, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 16, 2020 Opinion or Order Filing 35 TRANSFER ORDER re: pldg. ( #1 in MDL No. 2974) Transferring 49 action(s) to Judge Leigh Martin May in the N.D. Georgia.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTID ISTRICT LITIGATION, on 12/16/2020. Associated Cases: MDL No. 2974 et al. (LH)
December 16, 2020 Filing 34 OFFICIAL TRANSCRIPT of Hearing held on 12/3/2020 before the Panel at Washington, DC. Court Reporter/Transcriber Bryan Wayne, 333 Constitution Avenue, N.W., Room 4704-A, Washington, DC 20001, bryan_wayne@dcd.uscourts.gov. Transcript may be viewed at the Panel's office or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Redaction due 12/23/2020. Redaction Request due 1/6/2021. Redacted Transcript Deadline set for 1/16/2021. Release of Transcript Restriction set for 3/16/2021.Signed by Clerk of the Panel John W. Nichols on 12/16/2020. Associated Cases: MDL No. 2974, AZ/2:20-cv-01675, CAC/2:19-cv-10824, CAC/2:19-cv-10825, CAC/2:20-cv-00005, CAC/2:20-cv-07550, CAE/2:20-cv-00954, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, FLS/0:20-cv-61957, GAN/1:20-cv-03666, GAN/1:20-cv-03667, GAN/1:20-cv-03668, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, ID/1:20-cv-00022, ILN/1:20-cv-05193, ILS/3:20-cv-00494, LAE/2:20-cv-02261, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, MN/0:19-cv-03182, MN/0:20-cv-01871, MOW/4:20-cv-00687, MOW/4:20-cv-00744, MOW/4:20-cv-00746, MOW/4:20-cv-00747, NCE/5:20-cv-00442, NM/1:20-cv-00970, NM/2:20-cv-00809, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/1:20-cv-06683, NYS/7:20-cv-05942, NYS/7:20-cv-06448, OHS/1:20-cv-00938, OHS/2:20-cv-04210, PAE/2:20-cv-04483, PAM/1:20-cv-01529, PAM/1:20-cv-01536, SC/6:20-cv-03250, TNM/2:19-cv-00103, TXE/1:20-cv-00369, TXN/3:20-cv-02979, TXS/2:20-cv-00212, TXS/4:20-cv-00017, UT/1:19-cv-00148, UT/2:19-cv-00994, UT/2:20-cv-00586, VAE/1:20-cv-00921, WAW/2:20-cv-01384, WIE/2:20-cv-00585, WIE/2:20-cv-01296 (RH)
November 16, 2020 Filing 33 SUPPLEMENTAL NOTICE OF HEARING SESSION re: pldg. (20 in AZ/2:20-cv-01675, 20 in CAC/2:19-cv-10824, 20 in CAC/2:19-cv-10825, 20 in CAC/2:20-cv-00005, 16 in CAC/2:20-cv-07550, 14 in CAE/2:20-cv-00954, 20 in CO/1:20-cv-02921, 18 in FLM/8:20-cv-02002, 24 in FLM/8:20-cv-02087, 22 in FLN/4:20-cv-00378, 20 in FLS/0:20-cv-61957, 20 in GAN/1:20-cv-03666, 18 in GAN/1:20-cv-03667, 20 in GAN/1:20-cv-03668, 22 in GAN/1:20-cv-03719, 22 in GAN/1:20-cv-03942, 22 in GAN/1:20-cv-03945, 20 in ID/1:20-cv-00022, 20 in ILN/1:20-cv-05193, 18 in ILS/3:20-cv-00494, 16 in LAE/2:20-cv-02261, 22 in MD/1:20-cv-02435, #28 in MDL No. 2974, 22 in MIE/2:20-cv-12366, 20 in MN/0:19-cv-03182, 18 in MN/0:20-cv-01871, 20 in MOW/4:20-cv-00687, 18 in MOW/4:20-cv-00744, 18 in MOW/4:20-cv-00746, 18 in MOW/4:20-cv-00747, 20 in NCE/5:20-cv-00442, 18 in NM/1:20-cv-00970, 18 in NM/2:20-cv-00809, 22 in NYN/1:20-cv-01019, 22 in NYS/1:20-cv-04048, 20 in NYS/1:20-cv-06683, 22 in NYS/7:20-cv-05942, 20 in NYS/7:20-cv-06448, 16 in OHS/2:20-cv-04210, 20 in PAE/2:20-cv-04483, 20 in PAM/1:20-cv-01529, 20 in PAM/1:20-cv-01536, 22 in SC/6:20-cv-03250, 20 in TNM/2:19-cv-00103, 20 in TXE/1:20-cv-00369, 19 in TXN/3:20-cv-02979, 20 in TXS/2:20-cv-00212, 16 in TXS/4:20-cv-00017, 20 in UT/1:19-cv-00148, 20 in UT/2:19-cv-00994, 22 in UT/2:20-cv-00586, 20 in VAE/1:20-cv-00921, 20 in WAW/2:20-cv-01384, 16 in WIE/2:20-cv-00585, 20 in WIE/2:20-cv-01296) Signed by Clerk of the Panel John W. Nichols on 11/16/2020. Associated Cases: MDL No. 2974 et al. (dld)
November 9, 2020 Filing 32 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (20 in AZ/2:20-cv-01675, 20 in CAC/2:19-cv-10824, 20 in CAC/2:19-cv-10825, 20 in CAC/2:20-cv-00005, 20 in CO/1:20-cv-02921, 24 in FLM/8:20-cv-02087, 22 in FLN/4:20-cv-00378, 20 in FLS/0:20-cv-61957, 20 in GAN/1:20-cv-03666, 18 in GAN/1:20-cv-03667, 20 in GAN/1:20-cv-03668, 22 in GAN/1:20-cv-03719, 22 in GAN/1:20-cv-03942, 22 in GAN/1:20-cv-03945, 20 in ID/1:20-cv-00022, 20 in ILN/1:20-cv-05193, 18 in ILS/3:20-cv-00494, 22 in MD/1:20-cv-02435, 28 in MDL No. 2974, 22 in MIE/2:20-cv-12366, 20 in MN/0:19-cv-03182, 18 in MN/0:20-cv-01871, 20 in MOW/4:20-cv-00687, 18 in MOW/4:20-cv-00744, 18 in MOW/4:20-cv-00746, 18 in MOW/4:20-cv-00747, 20 in NCE/5:20-cv-00442, 18 in NM/1:20-cv-00970, 18 in NM/2:20-cv-00809, 22 in NYN/1:20-cv-01019, 22 in NYS/1:20-cv-04048, 20 in NYS/1:20-cv-06683, 22 in NYS/7:20-cv-05942, 20 in NYS/7:20-cv-06448, 20 in PAE/2:20-cv-04483, 20 in PAM/1:20-cv-01529, 20 in PAM/1:20-cv-01536, 22 in SC/6:20-cv-03250, 20 in TNM/2:19-cv-00103, 20 in TXE/1:20-cv-00369, 19 in TXN/3:20-cv-02979, 20 in TXS/2:20-cv-00212, 20 in UT/1:19-cv-00148, 20 in UT/2:19-cv-00994, 22 in UT/2:20-cv-00586, 20 in VAE/1:20-cv-00921, 20 in WAW/2:20-cv-01384, 20 in WIE/2:20-cv-01296), ( #1 in MDL No. 2974) Filed by Jeffrey Francis Peck on behalf of Defendants Coopersurgical, Inc., #et al.The Cooper Companies, Inc., Coopersurgical, Inc., #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2974 et al. (Peck, Jeffrey) DELETED DUPLICATE PARTIES NAMES Modified on 11/9/2020 (RH).
November 9, 2020 Filing 31 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (20 in AZ/2:20-cv-01675, 20 in CAC/2:19-cv-10824, 20 in CAC/2:19-cv-10825, 20 in CAC/2:20-cv-00005, 16 in CAC/2:20-cv-07550, 14 in CAE/2:20-cv-00954, 20 in CO/1:20-cv-02921, 18 in FLM/8:20-cv-02002, 24 in FLM/8:20-cv-02087, 22 in FLN/4:20-cv-00378, 20 in FLS/0:20-cv-61957, 20 in GAN/1:20-cv-03666, 18 in GAN/1:20-cv-03667, 20 in GAN/1:20-cv-03668, 22 in GAN/1:20-cv-03719, 22 in GAN/1:20-cv-03942, 22 in GAN/1:20-cv-03945, 20 in ID/1:20-cv-00022, 20 in ILN/1:20-cv-05193, 18 in ILS/3:20-cv-00494, 16 in LAE/2:20-cv-02261, 22 in MD/1:20-cv-02435, 28 in MDL No. 2974, 22 in MIE/2:20-cv-12366, 20 in MN/0:19-cv-03182, 18 in MN/0:20-cv-01871, 20 in MOW/4:20-cv-00687, 18 in MOW/4:20-cv-00744, 18 in MOW/4:20-cv-00746, 18 in MOW/4:20-cv-00747, 20 in NCE/5:20-cv-00442, 18 in NM/1:20-cv-00970, 18 in NM/2:20-cv-00809, 22 in NYN/1:20-cv-01019, 22 in NYS/1:20-cv-04048, 20 in NYS/1:20-cv-06683, 22 in NYS/7:20-cv-05942, 20 in NYS/7:20-cv-06448, 16 in OHS/2:20-cv-04210, 20 in PAE/2:20-cv-04483, 20 in PAM/1:20-cv-01529, 20 in PAM/1:20-cv-01536, 22 in SC/6:20-cv-03250, 20 in TNM/2:19-cv-00103, 20 in TXE/1:20-cv-00369, 19 in TXN/3:20-cv-02979, 20 in TXS/2:20-cv-00212, 16 in TXS/4:20-cv-00017, 20 in UT/1:19-cv-00148, 20 in UT/2:19-cv-00994, 22 in UT/2:20-cv-00586, 20 in VAE/1:20-cv-00921, 20 in WAW/2:20-cv-01384, 16 in WIE/2:20-cv-00585, 20 in WIE/2:20-cv-01296), ( #1 in MDL No. 2974) Filed by Frederick M. Erny on behalf of Defendants Teva Pharmaceuticals USA, Inc., #et al.Teva Women's Health Inc., Teva Women's Health, LLC, TEVA Pharmaceuticals, USA, Inc., Teva Branded Pharmaceutical Products R&D, Inc., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., TEVA WOMEN'S HEALTH INC., INDVIDIUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC. A DIVISION OF BARR PHARMACEUTICALS, INC., TEVA WOMEN'S HEALTH, LLC f/k/a TEVA WOMEN'S HEALTH, INC., INC. #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) DELETED DUPLICATE PARTIES NAMES Modified on 11/9/2020 (RH).
November 2, 2020 Filing 30 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #1 in MDL No. 2974) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Panel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel John W. Nichols on 11/2/2020. Associated Cases: MDL No. 2974 et al. (SM)
October 30, 2020 Filing 29 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. (22 in AZ/2:20-cv-01675, 22 in CAC/2:19-cv-10824, 22 in CAC/2:19-cv-10825, 22 in CAC/2:20-cv-00005, 18 in CAC/2:20-cv-07550, 16 in CAE/2:20-cv-00954, 22 in CO/1:20-cv-02921, 20 in FLM/8:20-cv-02002, 26 in FLM/8:20-cv-02087, 24 in FLN/4:20-cv-00378, 22 in FLS/0:20-cv-61957, 22 in GAN/1:20-cv-03666, 20 in GAN/1:20-cv-03667, 22 in GAN/1:20-cv-03668, 24 in GAN/1:20-cv-03719, 24 in GAN/1:20-cv-03942, 24 in GAN/1:20-cv-03945, 2 in HI/1:20-cv-00443, 2 in HI/1:20-cv-00444, 22 in ID/1:20-cv-00022, 13 in ID/1:20-cv-00477, 22 in ILN/1:20-cv-05193, 20 in ILS/3:20-cv-00494, 18 in LAE/2:20-cv-02261, 24 in MD/1:20-cv-02435, #31 in MDL No. 2974, 24 in MIE/2:20-cv-12366, 23 in MIE/4:20-cv-12248, 22 in MN/0:19-cv-03182, 20 in MN/0:20-cv-01871, 16 in MN/0:20-cv-02080, 16 in MN/0:20-cv-02081, 22 in MOW/4:20-cv-00687, 20 in MOW/4:20-cv-00744, 20 in MOW/4:20-cv-00746, 20 in MOW/4:20-cv-00747, 13 in MOW/4:20-cv-00796, 22 in NCE/5:20-cv-00442, 20 in NM/1:20-cv-00970, 20 in NM/2:20-cv-00809, 13 in NYE/1:20-cv-04835, 24 in NYN/1:20-cv-01019, 24 in NYS/1:20-cv-04048, 22 in NYS/1:20-cv-06683, 24 in NYS/7:20-cv-05942, 22 in NYS/7:20-cv-06448, 18 in OHS/2:20-cv-04210, 22 in PAE/2:20-cv-04483, 22 in PAM/1:20-cv-01529, 22 in PAM/1:20-cv-01536, 24 in SC/6:20-cv-03250, 22 in TNM/2:19-cv-00103, 22 in TXE/1:20-cv-00369, 5 in TXE/4:20-cv-00761, 21 in TXN/3:20-cv-02979, 22 in TXS/2:20-cv-00212, 18 in TXS/4:20-cv-00017, 5 in TXW/1:20-cv-01020, 22 in UT/1:19-cv-00148, 22 in UT/2:19-cv-00994, 24 in UT/2:20-cv-00586, 22 in VAE/1:20-cv-00921, 22 in WAW/2:20-cv-01384, 18 in WIE/2:20-cv-00585, 22 in WIE/2:20-cv-01296), ( #1 in MDL No. 2974) ( 30 in MDL No. 2974) ( #31 in MDL No. 2974) Filed by Plaintiff Latiesha Traylor (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2974 et al. (Welling, Lauren) Modified on 11/2/2020 (SM). ADDED MDL LINKS
October 28, 2020 Filing 28 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #33 in MDL No. 2974) ) -- Motion of: Defendants, Teva Pharmaceuticals USA, Inc., et al. to File Document Under Seal -- GRANTED. Signed by Clerk of the Panel John W. Nichols on 10/28/2020. Associated Cases: MDL No. 2974, AZ/2:20-cv-01675, CAC/2:19-cv-10824, CAC/2:19-cv-10825, CAC/2:20-cv-00005, CAC/2:20-cv-07550, CAE/2:20-cv-00954, CO/1:20-cv-02921, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, FLS/0:20-cv-61957, GAN/1:20-cv-03666, GAN/1:20-cv-03667, GAN/1:20-cv-03668, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, GAN/1:20-cv-04200, GAN/3:20-cv-00194, HI/1:20-cv-00443, HI/1:20-cv-00444, ID/1:20-cv-00022, ID/1:20-cv-00477, ILN/1:20-cv-05193, ILS/3:20-cv-00494, LAE/2:20-cv-02261, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, MN/0:19-cv-03182, MN/0:20-cv-01871, MN/0:20-cv-02080, MN/0:20-cv-02081, MOW/4:20-cv-00687, MOW/4:20-cv-00744, MOW/4:20-cv-00746, MOW/4:20-cv-00747, MOW/4:20-cv-00796, NCE/5:20-cv-00442, NM/1:20-cv-00970, NM/2:20-cv-00809, NYE/1:20-cv-04835, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/1:20-cv-06683, NYS/1:20-cv-07979, NYS/7:20-cv-05942, NYS/7:20-cv-06448, OHS/2:20-cv-04210, PAE/2:20-cv-04483, PAM/1:20-cv-01529, PAM/1:20-cv-01536, SC/6:20-cv-03250, TNM/2:19-cv-00103, TXE/1:20-cv-00369, TXE/4:20-cv-00761, TXN/3:20-cv-02979, TXS/2:20-cv-00212, TXS/4:20-cv-00017, TXW/1:20-cv-00989, TXW/1:20-cv-01020, UT/1:19-cv-00148, UT/2:19-cv-00994, UT/2:20-cv-00586, VAE/1:20-cv-00921, WAW/2:20-cv-01384, WIE/2:20-cv-00585, WIE/2:20-cv-01296 (JN)
October 28, 2020 Filing 27 ***SEALED DOCUMENT RECEIVED by the Clerk of the Panel (re: pldg. ( #33 in MDL No. 2974) ) Associated Cases: MDL No. 2974 et al. (JN)
October 27, 2020 Filing 26 Joint MOTION TO SEAL (File Document Under Seal) re: pldg. ( #31 in MDL No. 2804) Filed by Frederick M. Erny on behalf of Defendants Coopersurgical, Inc., #et al.TEVA BRANDED PHARMACEUTICALS PRODUCTS R&D INC, Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, Teva Womens Health Inc., The Cooper Companies Inc. #[Suppress List] (Attachments: #1 Memorandum, #2 Schedule of Actions, #3 Proof of Service, #4 Exhibit Estrada Doc 96, #5 Exhibit Estrada Doc 102) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/28/2020 (SM). DELETED DUPLICATE PARTY NAMES. ADDED MDL LINK
October 23, 2020 Filing 25 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #1 in MDL No. 2974), ( 28 in MDL No. 2974) Filed by Robert M Hammers, Jr on behalf of Plaintiffs Crystal White, #et al.Domonique Lewis, Haifa Al-Qawie, Tanya Johnson, Shelby Harnish, Vanesha Johnson, Carley Tredway, Dawn Schoenfeld, GUERTY GENOSIER, Patricia Rodriguez, Ada Lepine, Allison Lewis, Georgia Bowers, WHITNEY BRANCH, Erica McClarty #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2974, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, FLS/0:20-cv-61957, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/7:20-cv-05942, SC/6:20-cv-03250, UT/2:20-cv-00586 (Hammers, Robert) ADDED MDL LINK Modified on 10/26/2020 (RH).
October 23, 2020 Filing 24 RESPONSE IN OPPOSITION -- (re: pldg. ( #1 in MDL No. 2974) ) Filed by Defendants Coopersurgical, Inc., #et al.Teva Pharmaceuticals USA, Inc., Teva Women's Health Inc, Teva Women's Health, LLC, The Cooper Companies Inc, TEVA BRANDED PHARMACEUTICALS PRODUCTS R&D INC. #[Suppress List] (Attachments: #1 Exhibit 1, #2 Exhibit 2) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/26/2020 (SM). DELETED DUPLICATE PARTY NAMES
October 23, 2020 Filing 23 RESPONSE IN SUPPORT -- (re: pldg. ( #1 in MDL No. 2974) ) Filed by Plaintiff Patricia Rodriguez Associated Cases: MDL No. 2974 et al. (Hammers, Robert)
October 22, 2020 Opinion or Order Filing 22 HEARING ORDER re: pldg. ( #1 in MDL No. 2974) - SECTION A (DESIGNATED FOR ORAL ARGUMENT) PANEL HEARING set for 12/3/2020 in Washington, DC. Notices of Presentation or Waiver of Oral Argument due on or before 11/9/2020.#Notice of Presentation or Waiver of Oral Argument form (JPML form 9) can be downloaded from our website.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/22/2020. Associated Cases: MDL No. 2974 et al. (RH)
October 20, 2020 Filing 21 CERTIFICATE OF SERVICE re: pldg. (5 in FLM/8:20-cv-02002, 5 in FLM/8:20-cv-02087, 5 in FLN/4:20-cv-00378, 4 in FLS/0:20-cv-61957, 5 in GAN/1:20-cv-03719, 5 in GAN/1:20-cv-03942, 5 in GAN/1:20-cv-03945, 5 in MD/1:20-cv-02435, #7 in MDL No. 2974, 5 in MIE/2:20-cv-12366, 5 in MIE/4:20-cv-12248, 5 in NYN/1:20-cv-01019, 5 in NYS/1:20-cv-04048, 5 in NYS/7:20-cv-05942, 5 in SC/6:20-cv-03250, 5 in UT/2:20-cv-00586) Filed by Plaintiffs Crystal White, #et al.Domonique Lewis, Haifa Al-Qawie, Tanya Johnson, Shelby Harnish, Vanesha Johnson, Carley Tredway, Dawn Schoenfeld, GUERTY GENOSIER, Patricia Rodriguez, Ada Lepine, Allison Lewis, Georgia Bowers, WHITNEY BRANCH, Erica McClarty #[Suppress List] -- Associated Cases: MDL No. 2974, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, FLS/0:20-cv-61957, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/7:20-cv-05942, SC/6:20-cv-03250, UT/2:20-cv-00586 (Hammers, Robert)
October 20, 2020 Filing 20 WITHDRAWAL OF APPEARANCE (re: pldg. (4 in FLM/8:20-cv-02002, 4 in FLM/8:20-cv-02087, 4 in FLN/4:20-cv-00378, 4 in GAN/1:20-cv-03719, 4 in GAN/1:20-cv-03942, 4 in GAN/1:20-cv-03945, 4 in MD/1:20-cv-02435, #6 in MDL No. 2974, 4 in MIE/2:20-cv-12366, 4 in MIE/4:20-cv-12248, 4 in NYN/1:20-cv-01019, 4 in NYS/1:20-cv-04048, 4 in NYS/7:20-cv-05942, 4 in SC/6:20-cv-03250, 4 in UT/2:20-cv-00586) ) by Molly Long, Esq., Plaintiffs Crystal White, #et al.Domonique Lewis, Haifa Al-Qawie, Tanya Johnson, Shelby Harnish, Vanesha Johnson, Patricia Rodriguez, Allison Lewis, Ada Lepine, Georgia Bowers, WHITNEY BRANCH, Carley Tredway, Dawn Schoenfeld, Erica McClarty #[Suppress List]. (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2974, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/7:20-cv-05942, SC/6:20-cv-03250, UT/2:20-cv-00586 (Long, Molly)
October 16, 2020 Filing 19 ERRATA - to (8 in AZ/2:20-cv-01675, 8 in CAC/2:19-cv-10824, 8 in CAC/2:19-cv-10825, 8 in CAC/2:20-cv-00005, 8 in CO/1:20-cv-02921, 10 in FLM/8:20-cv-02087, 9 in FLN/4:20-cv-00378, 8 in FLS/0:20-cv-61957, 8 in GAN/1:20-cv-03666, 7 in GAN/1:20-cv-03667, 8 in GAN/1:20-cv-03668, 9 in GAN/1:20-cv-03719, 9 in GAN/1:20-cv-03942, 9 in GAN/1:20-cv-03945, 8 in ID/1:20-cv-00022, 2 in ID/1:20-cv-00477, 8 in ILN/1:20-cv-05193, 7 in ILS/3:20-cv-00494, 9 in MD/1:20-cv-02435, #13 in MDL No. 2974, 9 in MIE/2:20-cv-12366, 9 in MIE/4:20-cv-12248, 8 in MN/0:19-cv-03182, 7 in MN/0:20-cv-01871, 4 in MN/0:20-cv-02080, 4 in MN/0:20-cv-02081, 8 in MOW/4:20-cv-00687, 7 in MOW/4:20-cv-00744, 7 in MOW/4:20-cv-00746, 7 in MOW/4:20-cv-00747, 2 in MOW/4:20-cv-00796, 8 in NCE/5:20-cv-00442, 7 in NM/1:20-cv-00970, 7 in NM/2:20-cv-00809, 2 in NYE/1:20-cv-04835, 9 in NYN/1:20-cv-01019, 9 in NYS/1:20-cv-04048, 8 in NYS/1:20-cv-06683, 9 in NYS/7:20-cv-05942, 8 in NYS/7:20-cv-06448, 8 in PAE/2:20-cv-04483, 8 in PAM/1:20-cv-01529, 8 in PAM/1:20-cv-01536, 9 in SC/6:20-cv-03250, 8 in TNM/2:19-cv-00103, 8 in TXE/1:20-cv-00369, 8 in TXN/3:20-cv-02979, 8 in TXS/2:20-cv-00212, 8 in UT/1:19-cv-00148, 8 in UT/2:19-cv-00994, 9 in UT/2:20-cv-00586, 8 in VAE/1:20-cv-00921, 8 in WAW/2:20-cv-01384, 8 in WIE/2:20-cv-01296), (6 in AZ/2:20-cv-01675, 6 in CAC/2:19-cv-10824, 6 in CAC/2:19-cv-10825, 6 in CAC/2:20-cv-00005, 6 in CO/1:20-cv-02921, 8 in FLM/8:20-cv-02087, 7 in FLN/4:20-cv-00378, 6 in FLS/0:20-cv-61957, 6 in GAN/1:20-cv-03666, 5 in GAN/1:20-cv-03667, 6 in GAN/1:20-cv-03668, 7 in GAN/1:20-cv-03719, 7 in GAN/1:20-cv-03942, 7 in GAN/1:20-cv-03945, 6 in ID/1:20-cv-00022, 6 in ILN/1:20-cv-05193, 5 in ILS/3:20-cv-00494, 7 in MD/1:20-cv-02435, #11 in MDL No. 2974, 7 in MIE/2:20-cv-12366, 7 in MIE/4:20-cv-12248, 6 in MN/0:19-cv-03182, 5 in MN/0:20-cv-01871, 2 in MN/0:20-cv-02080, 2 in MN/0:20-cv-02081, 6 in MOW/4:20-cv-00687, 5 in MOW/4:20-cv-00744, 5 in MOW/4:20-cv-00746, 5 in MOW/4:20-cv-00747, 6 in NCE/5:20-cv-00442, 5 in NM/1:20-cv-00970, 5 in NM/2:20-cv-00809, 7 in NYN/1:20-cv-01019, 7 in NYS/1:20-cv-04048, 6 in NYS/1:20-cv-06683, 7 in NYS/7:20-cv-05942, 6 in NYS/7:20-cv-06448, 6 in PAE/2:20-cv-04483, 6 in PAM/1:20-cv-01529, 6 in PAM/1:20-cv-01536, 7 in SC/6:20-cv-03250, 6 in TNM/2:19-cv-00103, 6 in TXE/1:20-cv-00369, 6 in TXN/3:20-cv-02979, 6 in TXS/2:20-cv-00212, 6 in UT/1:19-cv-00148, 6 in UT/2:19-cv-00994, 7 in UT/2:20-cv-00586, 6 in VAE/1:20-cv-00921, 6 in WAW/2:20-cv-01384, 6 in WIE/2:20-cv-01296), (7 in AZ/2:20-cv-01675, 7 in CAC/2:19-cv-10824, 7 in CAC/2:19-cv-10825, 7 in CAC/2:20-cv-00005, 7 in CO/1:20-cv-02921, 9 in FLM/8:20-cv-02087, 8 in FLN/4:20-cv-00378, 7 in FLS/0:20-cv-61957, 7 in GAN/1:20-cv-03666, 6 in GAN/1:20-cv-03667, 7 in GAN/1:20-cv-03668, 8 in GAN/1:20-cv-03719, 8 in GAN/1:20-cv-03942, 8 in GAN/1:20-cv-03945, 7 in ID/1:20-cv-00022, 1 in ID/1:20-cv-00477, 7 in ILN/1:20-cv-05193, 6 in ILS/3:20-cv-00494, 8 in MD/1:20-cv-02435, #12 in MDL No. 2974, 8 in MIE/2:20-cv-12366, 8 in MIE/4:20-cv-12248, 7 in MN/0:19-cv-03182, 6 in MN/0:20-cv-01871, 3 in MN/0:20-cv-02080, 3 in MN/0:20-cv-02081, 7 in MOW/4:20-cv-00687, 6 in MOW/4:20-cv-00744, 6 in MOW/4:20-cv-00746, 6 in MOW/4:20-cv-00747, 1 in MOW/4:20-cv-00796, 7 in NCE/5:20-cv-00442, 6 in NM/1:20-cv-00970, 6 in NM/2:20-cv-00809, 1 in NYE/1:20-cv-04835, 8 in NYN/1:20-cv-01019, 8 in NYS/1:20-cv-04048, 7 in NYS/1:20-cv-06683, 8 in NYS/7:20-cv-05942, 7 in NYS/7:20-cv-06448, 7 in PAE/2:20-cv-04483, 7 in PAM/1:20-cv-01529, 7 in PAM/1:20-cv-01536, 8 in SC/6:20-cv-03250, 7 in TNM/2:19-cv-00103, 7 in TXE/1:20-cv-00369, 7 in TXN/3:20-cv-02979, 7 in TXS/2:20-cv-00212, 7 in UT/1:19-cv-00148, 7 in UT/2:19-cv-00994, 8 in UT/2:20-cv-00586, 7 in VAE/1:20-cv-00921, 7 in WAW/2:20-cv-01384, 7 in WIE/2:20-cv-01296) - Filed by Defendants Coopersurgical, Inc., #et al.The Cooper Companies, Inc. #[Suppress List] Associated Cases: MDL No. 2974 et al. (Peck, Jeffrey) Modified on 10/19/2020 (SM). DELETED DUPLICATE PARTY NAMES
October 16, 2020 Filing 18 ERRATA - to (5 in AZ/2:20-cv-01675, 5 in CAC/2:19-cv-10824, 5 in CAC/2:19-cv-10825, 5 in CAC/2:20-cv-00005, 5 in CAC/2:20-cv-07550, 4 in CAE/2:20-cv-00954, 5 in CO/1:20-cv-02921, 6 in FLM/8:20-cv-02002, 7 in FLM/8:20-cv-02087, 6 in FLN/4:20-cv-00378, 5 in FLS/0:20-cv-61957, 5 in GAN/1:20-cv-03666, 4 in GAN/1:20-cv-03667, 5 in GAN/1:20-cv-03668, 6 in GAN/1:20-cv-03719, 6 in GAN/1:20-cv-03942, 6 in GAN/1:20-cv-03945, 5 in ID/1:20-cv-00022, 5 in ILN/1:20-cv-05193, 4 in ILS/3:20-cv-00494, 5 in LAE/2:20-cv-02261, 6 in MD/1:20-cv-02435, #10 in MDL No. 2974, 6 in MIE/2:20-cv-12366, 6 in MIE/4:20-cv-12248, 5 in MN/0:19-cv-03182, 4 in MN/0:20-cv-01871, 1 in MN/0:20-cv-02080, 1 in MN/0:20-cv-02081, 5 in MOW/4:20-cv-00687, 4 in MOW/4:20-cv-00744, 4 in MOW/4:20-cv-00746, 4 in MOW/4:20-cv-00747, 5 in NCE/5:20-cv-00442, 4 in NM/1:20-cv-00970, 4 in NM/2:20-cv-00809, 6 in NYN/1:20-cv-01019, 6 in NYS/1:20-cv-04048, 5 in NYS/1:20-cv-06683, 6 in NYS/7:20-cv-05942, 5 in NYS/7:20-cv-06448, 5 in OHS/2:20-cv-04210, 5 in PAE/2:20-cv-04483, 5 in PAM/1:20-cv-01529, 5 in PAM/1:20-cv-01536, 6 in SC/6:20-cv-03250, 5 in TNM/2:19-cv-00103, 5 in TXE/1:20-cv-00369, 5 in TXN/3:20-cv-02979, 5 in TXS/2:20-cv-00212, 5 in TXS/4:20-cv-00017, 5 in UT/1:19-cv-00148, 5 in UT/2:19-cv-00994, 6 in UT/2:20-cv-00586, 5 in VAE/1:20-cv-00921, 5 in WAW/2:20-cv-01384, 5 in WIE/2:20-cv-00585, 5 in WIE/2:20-cv-01296), (13 in AZ/2:20-cv-01675, 13 in CAC/2:19-cv-10824, 13 in CAC/2:19-cv-10825, 13 in CAC/2:20-cv-00005, 10 in CAC/2:20-cv-07550, 9 in CAE/2:20-cv-00954, 13 in CO/1:20-cv-02921, 11 in FLM/8:20-cv-02002, 15 in FLM/8:20-cv-02087, 14 in FLN/4:20-cv-00378, 13 in FLS/0:20-cv-61957, 13 in GAN/1:20-cv-03666, 12 in GAN/1:20-cv-03667, 13 in GAN/1:20-cv-03668, 14 in GAN/1:20-cv-03719, 14 in GAN/1:20-cv-03942, 14 in GAN/1:20-cv-03945, 13 in ID/1:20-cv-00022, 13 in ILN/1:20-cv-05193, 12 in ILS/3:20-cv-00494, 10 in LAE/2:20-cv-02261, 14 in MD/1:20-cv-02435, #18 in MDL No. 2974, 14 in MIE/2:20-cv-12366, 14 in MIE/4:20-cv-12248, 13 in MN/0:19-cv-03182, 12 in MN/0:20-cv-01871, 9 in MN/0:20-cv-02080, 9 in MN/0:20-cv-02081, 13 in MOW/4:20-cv-00687, 12 in MOW/4:20-cv-00744, 12 in MOW/4:20-cv-00746, 12 in MOW/4:20-cv-00747, 13 in NCE/5:20-cv-00442, 12 in NM/1:20-cv-00970, 12 in NM/2:20-cv-00809, 14 in NYN/1:20-cv-01019, 14 in NYS/1:20-cv-04048, 13 in NYS/1:20-cv-06683, 14 in NYS/7:20-cv-05942, 13 in NYS/7:20-cv-06448, 10 in OHS/2:20-cv-04210, 13 in PAE/2:20-cv-04483, 13 in PAM/1:20-cv-01529, 13 in PAM/1:20-cv-01536, 14 in SC/6:20-cv-03250, 13 in TNM/2:19-cv-00103, 13 in TXE/1:20-cv-00369, 13 in TXN/3:20-cv-02979, 13 in TXS/2:20-cv-00212, 10 in TXS/4:20-cv-00017, 13 in UT/1:19-cv-00148, 13 in UT/2:19-cv-00994, 14 in UT/2:20-cv-00586, 13 in VAE/1:20-cv-00921, 13 in WAW/2:20-cv-01384, 10 in WIE/2:20-cv-00585, 13 in WIE/2:20-cv-01296), (11 in AZ/2:20-cv-01675, 11 in CAC/2:19-cv-10824, 11 in CAC/2:19-cv-10825, 11 in CAC/2:20-cv-00005, 8 in CAC/2:20-cv-07550, 7 in CAE/2:20-cv-00954, 11 in CO/1:20-cv-02921, 9 in FLM/8:20-cv-02002, 13 in FLM/8:20-cv-02087, 12 in FLN/4:20-cv-00378, 11 in FLS/0:20-cv-61957, 11 in GAN/1:20-cv-03666, 10 in GAN/1:20-cv-03667, 11 in GAN/1:20-cv-03668, 12 in GAN/1:20-cv-03719, 12 in GAN/1:20-cv-03942, 12 in GAN/1:20-cv-03945, 11 in ID/1:20-cv-00022, 5 in ID/1:20-cv-00477, 11 in ILN/1:20-cv-05193, 10 in ILS/3:20-cv-00494, 8 in LAE/2:20-cv-02261, 12 in MD/1:20-cv-02435, #16 in MDL No. 2974, 12 in MIE/2:20-cv-12366, 12 in MIE/4:20-cv-12248, 11 in MN/0:19-cv-03182, 10 in MN/0:20-cv-01871, 7 in MN/0:20-cv-02080, 7 in MN/0:20-cv-02081, 11 in MOW/4:20-cv-00687, 10 in MOW/4:20-cv-00744, 10 in MOW/4:20-cv-00746, 10 in MOW/4:20-cv-00747, 5 in MOW/4:20-cv-00796, 11 in NCE/5:20-cv-00442, 10 in NM/1:20-cv-00970, 10 in NM/2:20-cv-00809, 5 in NYE/1:20-cv-04835, 12 in NYN/1:20-cv-01019, 12 in NYS/1:20-cv-04048, 11 in NYS/1:20-cv-06683, 12 in NYS/7:20-cv-05942, 11 in NYS/7:20-cv-06448, 8 in OHS/2:20-cv-04210, 11 in PAE/2:20-cv-04483, 11 in PAM/1:20-cv-01529, 11 in PAM/1:20-cv-01536, 12 in SC/6:20-cv-03250, 11 in TNM/2:19-cv-00103, 11 in TXE/1:20-cv-00369, 11 in TXN/3:20-cv-02979, 11 in TXS/2:20-cv-00212, 8 in TXS/4:20-cv-00017, 11 in UT/1:19-cv-00148, 11 in UT/2:19-cv-00994, 12 in UT/2:20-cv-00586, 11 in VAE/1:20-cv-00921, 11 in WAW/2:20-cv-01384, 8 in WIE/2:20-cv-00585, 11 in WIE/2:20-cv-01296), (9 in AZ/2:20-cv-01675, 9 in CAC/2:19-cv-10824, 9 in CAC/2:19-cv-10825, 9 in CAC/2:20-cv-00005, 6 in CAC/2:20-cv-07550, 5 in CAE/2:20-cv-00954, 9 in CO/1:20-cv-02921, 7 in FLM/8:20-cv-02002, 11 in FLM/8:20-cv-02087, 10 in FLN/4:20-cv-00378, 9 in FLS/0:20-cv-61957, 9 in GAN/1:20-cv-03666, 8 in GAN/1:20-cv-03667, 9 in GAN/1:20-cv-03668, 10 in GAN/1:20-cv-03719, 10 in GAN/1:20-cv-03942, 10 in GAN/1:20-cv-03945, 9 in ID/1:20-cv-00022, 3 in ID/1:20-cv-00477, 9 in ILN/1:20-cv-05193, 8 in ILS/3:20-cv-00494, 6 in LAE/2:20-cv-02261, 10 in MD/1:20-cv-02435, #14 in MDL No. 2974, 10 in MIE/2:20-cv-12366, 10 in MIE/4:20-cv-12248, 9 in MN/0:19-cv-03182, 8 in MN/0:20-cv-01871, 5 in MN/0:20-cv-02080, 5 in MN/0:20-cv-02081, 9 in MOW/4:20-cv-00687, 8 in MOW/4:20-cv-00744, 8 in MOW/4:20-cv-00746, 8 in MOW/4:20-cv-00747, 3 in MOW/4:20-cv-00796, 9 in NCE/5:20-cv-00442, 8 in NM/1:20-cv-00970, 8 in NM/2:20-cv-00809, 3 in NYE/1:20-cv-04835, 10 in NYN/1:20-cv-01019, 10 in NYS/1:20-cv-04048, 9 in NYS/1:20-cv-06683, 10 in NYS/7:20-cv-05942, 9 in NYS/7:20-cv-06448, 6 in OHS/2:20-cv-04210, 9 in PAE/2:20-cv-04483, 9 in PAM/1:20-cv-01529, 9 in PAM/1:20-cv-01536, 10 in SC/6:20-cv-03250, 9 in TNM/2:19-cv-00103, 9 in TXE/1:20-cv-00369, 9 in TXN/3:20-cv-02979, 9 in TXS/2:20-cv-00212, 6 in TXS/4:20-cv-00017, 9 in UT/1:19-cv-00148, 9 in UT/2:19-cv-00994, 10 in UT/2:20-cv-00586, 9 in VAE/1:20-cv-00921, 9 in WAW/2:20-cv-01384, 6 in WIE/2:20-cv-00585, 9 in WIE/2:20-cv-01296), (12 in AZ/2:20-cv-01675, 12 in CAC/2:19-cv-10824, 12 in CAC/2:19-cv-10825, 12 in CAC/2:20-cv-00005, 9 in CAC/2:20-cv-07550, 8 in CAE/2:20-cv-00954, 12 in CO/1:20-cv-02921, 10 in FLM/8:20-cv-02002, 14 in FLM/8:20-cv-02087, 13 in FLN/4:20-cv-00378, 12 in FLS/0:20-cv-61957, 12 in GAN/1:20-cv-03666, 11 in GAN/1:20-cv-03667, 12 in GAN/1:20-cv-03668, 13 in GAN/1:20-cv-03719, 13 in GAN/1:20-cv-03942, 13 in GAN/1:20-cv-03945, 12 in ID/1:20-cv-00022, 6 in ID/1:20-cv-00477, 12 in ILN/1:20-cv-05193, 11 in ILS/3:20-cv-00494, 9 in LAE/2:20-cv-02261, 13 in MD/1:20-cv-02435, 17 in MDL No. 2974, 13 in MIE/2:20-cv-12366, 13 in MIE/4:20-cv-12248, 12 in MN/0:19-cv-03182, 11 in MN/0:20-cv-01871, 8 in MN/0:20-cv-02080, 8 in MN/0:20-cv-02081, 12 in MOW/4:20-cv-00687, 11 in MOW/4:20-cv-00744, 11 in MOW/4:20-cv-00746, 11 in MOW/4:20-cv-00747, 6 in MOW/4:20-cv-00796, 12 in NCE/5:20-cv-00442, 11 in NM/1:20-cv-00970, 11 in NM/2:20-cv-00809, 6 in NYE/1:20-cv-04835, 13 in NYN/1:20-cv-01019, 13 in NYS/1:20-cv-04048, 12 in NYS/1:20-cv-06683, 13 in NYS/7:20-cv-05942, 12 in NYS/7:20-cv-06448, 9 in OHS/2:20-cv-04210, 12 in PAE/2:20-cv-04483, 12 in PAM/1:20-cv-01529, 12 in PAM/1:20-cv-01536, 13 in SC/6:20-cv-03250, 12 in TNM/2:19-cv-00103, 12 in TXE/1:20-cv-00369, 12 in TXN/3:20-cv-02979, 12 in TXS/2:20-cv-00212, 9 in TXS/4:20-cv-00017, 12 in UT/1:19-cv-00148, 12 in UT/2:19-cv-00994, 13 in UT/2:20-cv-00586, 12 in VAE/1:20-cv-00921, 12 in WAW/2:20-cv-01384, 9 in WIE/2:20-cv-00585, 12 in WIE/2:20-cv-01296) - Filed by Defendants Teva Pharmaceuticals USA, Inc., #et al.Teva Women's Health Inc, Teva Women's Health, LLC, Teva Branded Pharmaceutical Products R&D, Inc. #[Suppress List] Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/19/2020 (SM). DELETED DUPLICATE PARTY NAMES
October 13, 2020 Filing 17 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #20 in MDL No. 2974), ( #19 in MDL No. 2974) )Motions of Defendants Teva Pharmaceuticals USA, Inc., et al., and Defendants The Cooper Companies, Inc., et al. for Extension of Time to Respond to Motion -- GRANTED IN PART TO ALL PARTIES. Responses due on or before 10/23/2020. Reply, if any, due on or before 10/30/2020. Signed by Clerk of the Panel John W. Nichols on 10/13/2020. Associated Cases: MDL No. 2974, AZ/2:20-cv-01675, CAC/2:19-cv-10824, CAC/2:19-cv-10825, CAC/2:20-cv-00005, CAC/2:20-cv-07550, CAE/2:20-cv-00954, CO/1:20-cv-02921, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, FLS/0:20-cv-61957, GAN/1:20-cv-03666, GAN/1:20-cv-03667, GAN/1:20-cv-03668, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, ID/1:20-cv-00022, ID/1:20-cv-00477, ILN/1:20-cv-05193, ILS/3:20-cv-00494, LAE/2:20-cv-02261, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, MN/0:19-cv-03182, MN/0:20-cv-01871, MN/0:20-cv-02080, MN/0:20-cv-02081, MOW/4:20-cv-00687, MOW/4:20-cv-00744, MOW/4:20-cv-00746, MOW/4:20-cv-00747, MOW/4:20-cv-00796, NCE/5:20-cv-00442, NM/1:20-cv-00970, NM/2:20-cv-00809, NYE/1:20-cv-04835, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/1:20-cv-06683, NYS/7:20-cv-05942, NYS/7:20-cv-06448, OHS/2:20-cv-04210, PAE/2:20-cv-04483, PAM/1:20-cv-01529, PAM/1:20-cv-01536, SC/6:20-cv-03250, TNM/2:19-cv-00103, TXE/1:20-cv-00369, TXE/4:20-cv-00761, TXN/3:20-cv-02979, TXS/2:20-cv-00212, TXS/4:20-cv-00017, TXW/1:20-cv-01020, UT/1:19-cv-00148, UT/2:19-cv-00994, UT/2:20-cv-00586, VAE/1:20-cv-00921, WAW/2:20-CV-01384, WIE/2:20-cv-00585, WIE/2:20-cv-01296 (JN)
October 12, 2020 Filing 16 MOTION FOR EXTENSION OF TIME TO FILE RESPONSE re: pldg. ( #1 in MDL No. 2974) Filed by Jeffrey Francis Peck on behalf of Defendants The Cooper Companies, Inc., Coopersurgical, Inc. Associated Cases: MDL No. 2974 et al. (Peck, Jeffrey)
October 12, 2020 Filing 15 MOTION FOR EXTENSION OF TIME TO FILE RESPONSE re: pldg. ( #1 in MDL No. 2974) Filed by Frederick M. Erny on behalf of Defendants Teva Pharmaceuticals USA, Inc., #et al.Teva Women's Health Inc., Teva Women's Health, LLC #[Suppress List] Associated Cases: MDL No. 2974 et al. (Erny, Frederick)
October 9, 2020 Filing 14 CORPORATE DISCLOSURE STATEMENT (AMENDED) - re: pldg. (10 in AZ/2:20-cv-01675, 10 in CAC/2:19-cv-10824, 10 in CAC/2:19-cv-10825, 10 in CAC/2:20-cv-00005, 7 in CAC/2:20-cv-07550, 6 in CAE/2:20-cv-00954, 10 in CO/1:20-cv-02921, 8 in FLM/8:20-cv-02002, 12 in FLM/8:20-cv-02087, 11 in FLN/4:20-cv-00378, 10 in FLS/0:20-cv-61957, 10 in GAN/1:20-cv-03666, 9 in GAN/1:20-cv-03667, 10 in GAN/1:20-cv-03668, 11 in GAN/1:20-cv-03719, 11 in GAN/1:20-cv-03942, 11 in GAN/1:20-cv-03945, 10 in ID/1:20-cv-00022, 10 in ILN/1:20-cv-05193, 9 in ILS/3:20-cv-00494, 7 in LAE/2:20-cv-02261, 11 in MD/1:20-cv-02435, #15 in MDL No. 2974, 11 in MIE/2:20-cv-12366, 11 in MIE/4:20-cv-12248, 10 in MN/0:19-cv-03182, 9 in MN/0:20-cv-01871, 6 in MN/0:20-cv-02080, 6 in MN/0:20-cv-02081, 10 in MOW/4:20-cv-00687, 9 in MOW/4:20-cv-00744, 9 in MOW/4:20-cv-00746, 9 in MOW/4:20-cv-00747, 10 in NCE/5:20-cv-00442, 9 in NM/1:20-cv-00970, 9 in NM/2:20-cv-00809, 11 in NYN/1:20-cv-01019, 11 in NYS/1:20-cv-04048, 10 in NYS/1:20-cv-06683, 11 in NYS/7:20-cv-05942, 10 in NYS/7:20-cv-06448, 7 in OHS/2:20-cv-04210, 10 in PAE/2:20-cv-04483, 10 in PAM/1:20-cv-01529, 10 in PAM/1:20-cv-01536, 11 in SC/6:20-cv-03250, 10 in TNM/2:19-cv-00103, 10 in TXE/1:20-cv-00369, 10 in TXN/3:20-cv-02979, 10 in TXS/2:20-cv-00212, 7 in TXS/4:20-cv-00017, 10 in UT/1:19-cv-00148, 10 in UT/2:19-cv-00994, 11 in UT/2:20-cv-00586, 10 in VAE/1:20-cv-00921, 10 in WAW/2:20-CV-01384, 7 in WIE/2:20-cv-00585, 10 in WIE/2:20-cv-01296) Identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for TEVA WOMEN'S HEALTH, LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 13 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2974) -- Identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for TEVA PHARMACEUTICALS USA INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 12 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2974) -- Identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 11 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2974) -- Identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for TEVA WOMEN'S HEALTH, LLC. (Attachments: #1 Schedule of Actions, #2 Other) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2974) -- Identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for TEVA WOMEN'S HEALTH INC.(Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 9 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2974) -- Identifying Corporate Parent The Cooper Companies, Inc. for COOPERSURGICAL INC (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Peck, Jeffrey) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 8 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2974) -- Identifying Corporate Parent No Parent Corp., Non-Party/Financial Interest T. Rowe Price Associates, Inc., Non-Party/Financial Interest Vanguard Group, Inc. for COOPER COMPANIES INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Peck, Jeffrey) Modified on 10/13/2020 (SM).DELETED DUPLICATE PARTY NAME
October 9, 2020 Filing 7 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 2974) Filed by Jeffrey Francis Peck on behalf of Defendants Coopersurgical, Inc., #et al.The Cooper Companies, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Peck, Jeffrey) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAMES
October 9, 2020 Filing 6 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 2974) Filed by Frederick M. Erny on behalf of Defendants Teva Pharmaceuticals USA, Inc., #et al.Teva Women's Health Inc., Teva Women's Health, LLC, Teva Branded Pharmaceutical Products R&D, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2974 et al. (Erny, Frederick) Modified on 10/13/2020 (SM). DELETED DUPLICATE PARTY NAMES
October 8, 2020 Filing 5 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 2974) Filed by Robert M Hammers, Jr on behalf of Plaintiffs Crystal White, #et al.Domonique Lewis, Haifa Al-Qawie, Tanya Johnson, Shelby Harnish, Vanesha Johnson, Carley Tredway, Dawn Schoenfeld, GUERTY GENOSIER, Patricia Rodriguez, Ada Lepine, Allison Lewis, Georgia Bowers, WHITNEY BRANCH, Erica McClarty #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2974, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, FLS/0:20-cv-61957, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/7:20-cv-05942, SC/6:20-cv-03250, UT/2:20-cv-00586 (Hammers, Robert)
October 7, 2020 Filing 4 PLEADING WITHDRAWN SEE PLEADING #26 IN MDL No. 2974 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 2974) Filed by Molly Long on behalf of Plaintiffs Crystal White, #et al.Domonique Lewis, Haifa Al-Qawie, Tanya Johnson, Shelby Harnish, Vanesha Johnson, Patricia Rodriguez, Allison Lewis, Ada Lepine, Georgia Bowers, WHITNEY BRANCH, Carley Tredway, Dawn Schoenfeld, Erica McClarty #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2974, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/7:20-cv-05942, SC/6:20-cv-03250, UT/2:20-cv-00586 (Long, Molly) Modified on 10/22/2020 (SM). ADDED NOTATION
September 25, 2020 Filing 3 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 2974) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 10/9/2020. Corporate Disclosure Statements due on or before 10/9/2020. Responses due on or before 10/16/2020. Reply, if any, due on or before 10/23/2020. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 9/25/2020. Associated Cases: MDL No. 2974, AZ/2:20-cv-01675, CAC/2:19-cv-10824, CAC/2:19-cv-10825, CAC/2:20-cv-00005, CAC/2:20-cv-07550, CAE/2:20-cv-00954, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, GAN/1:20-cv-03666, GAN/1:20-cv-03667, GAN/1:20-cv-03668, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, ID/1:20-cv-00022, ILN/1:20-cv-05193, ILS/3:20-cv-00494, LAE/2:20-cv-02261, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, MN/0:19-cv-03182, MN/0:20-cv-01871, MOW/4:20-cv-00687, MOW/4:20-cv-00744, MOW/4:20-cv-00746, MOW/4:20-cv-00747, NCE/5:20-cv-00442, NM/1:20-cv-00970, NM/2:20-cv-00809, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/1:20-cv-06683, NYS/7:20-cv-05942, NYS/7:20-cv-06448, OHS/2:20-cv-04210, PAE/2:20-cv-04137, PAE/2:20-cv-04350, PAE/2:20-cv-04358, PAE/2:20-cv-04483, PAM/1:20-cv-01529, PAM/1:20-cv-01536, SC/6:20-cv-03250, TNM/2:19-cv-00103, TXE/1:20-cv-00369, TXS/2:20-cv-00212, TXS/4:20-cv-00017, UT/1:19-cv-00148, UT/2:19-cv-00994, UT/2:20-cv-00586, VAE/1:20-cv-00921, WAW/2:20-CV-01384, WIE/2:20-cv-00585, WIE/2:20-cv-01296 (DP)
September 25, 2020 Filing 2 MDL Number 2974 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 137) Associated Cases: Pending No. 137, AZ/2:20-cv-01675, CAC/2:19-cv-10824, CAC/2:19-cv-10825, CAC/2:20-cv-00005, CAC/2:20-cv-07550, CAE/2:20-cv-00954, FLM/8:20-cv-02002, FLM/8:20-cv-02087, FLN/4:20-cv-00378, GAN/1:20-cv-03666, GAN/1:20-cv-03667, GAN/1:20-cv-03668, GAN/1:20-cv-03719, GAN/1:20-cv-03942, GAN/1:20-cv-03945, ID/1:20-cv-00022, ILN/1:20-cv-05193, ILS/3:20-cv-00494, LAE/2:20-cv-02261, MD/1:20-cv-02435, MIE/2:20-cv-12366, MIE/4:20-cv-12248, MN/0:19-cv-03182, MN/0:20-cv-01871, MOW/4:20-cv-00687, MOW/4:20-cv-00744, MOW/4:20-cv-00746, MOW/4:20-cv-00747, NCE/5:20-cv-00442, NM/1:20-cv-00970, NM/2:20-cv-00809, NYN/1:20-cv-01019, NYS/1:20-cv-04048, NYS/1:20-cv-06683, NYS/7:20-cv-05942, NYS/7:20-cv-06448, OHS/2:20-cv-04210, PAE/2:20-cv-04137, PAE/2:20-cv-04350, PAE/2:20-cv-04358, PAE/2:20-cv-04483, PAM/1:20-cv-01529, PAM/1:20-cv-01536, SC/6:20-cv-03250, TNM/2:19-cv-00103, TXE/1:20-cv-00369, TXS/2:20-cv-00212, TXS/4:20-cv-00017, UT/1:19-cv-00148, UT/2:19-cv-00994, UT/2:20-cv-00586, VAE/1:20-cv-00921, WAW/2:20-CV-01384, WIE/2:20-cv-00585, WIE/2:20-cv-01296 (DP)
September 25, 2020 Filing 1 MOTION TO TRANSFER (CORRECTED) -- (re: pldg. #1 ) Correcting the following items: Proof of service, -- Filed by: Plaintiff Latiesha Traylor -- Associated Cases: Pending No. 137 et al. (Welling, Lauren) Modified on 9/25/2020 (DP)(EDITED EVENT TYPE).

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: Lewis v. Teva Pharmaceuticals USA, Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Lewis
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Allison Lewis
Represented By: Molly Long
Represented By: Robert M Hammers, Jr
Represented By: Fidelma Fitzpatrick
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc.
Represented By: W Patrick Sullivan
Represented By: Barry S. Cobb
Represented By: Tracy H. Fowler
Represented By: Kathleen M. Rhoads
Represented By: Thomas G McIntosh
Represented By: Celeste R Coco-Ewing
Represented By: Jennifer Snyder Heis
Represented By: Daniel Jay Gerber
Represented By: Tracy J. Van Steenburgh
Represented By: Laura E DeSantos
Represented By: Timothy Gage Harvey
Represented By: Ellison F Hitt
Represented By: Rex A Littrell
Represented By: Allison L. Jones
Represented By: Mary Lynn Tate
Represented By: Kelly Marie Lippincott
Represented By: Brian Rubenstein
Represented By: George F Verschelden
Represented By: David A Landman
Represented By: Timothy L. Warnock
Represented By: Frederick M. Erny
Represented By: Lisa Marlo Kuhnell
Represented By: Celeste R. Coco-Ewing
Represented By: Rex Allen Littrell
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Women's Health, LLC
Represented By: W Patrick Sullivan
Represented By: Barry S. Cobb
Represented By: Tracy H. Fowler
Represented By: Kathleen M. Rhoads
Represented By: Thomas G McIntosh
Represented By: Celeste R Coco-Ewing
Represented By: Jennifer Snyder Heis
Represented By: Daniel Jay Gerber
Represented By: Tracy J. Van Steenburgh
Represented By: Laura E DeSantos
Represented By: Timothy Gage Harvey
Represented By: Ellison F Hitt
Represented By: Rex A Littrell
Represented By: Allison L. Jones
Represented By: Mary Lynn Tate
Represented By: Kelly Marie Lippincott
Represented By: Brian Rubenstein
Represented By: George F Verschelden
Represented By: David A Landman
Represented By: Timothy L. Warnock
Represented By: Frederick M. Erny
Represented By: Lisa Marlo Kuhnell
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Women's Health, Inc. doing business as Teva Women's Health, LLC
Represented By: W Patrick Sullivan
Represented By: Barry S. Cobb
Represented By: Tracy H. Fowler
Represented By: Kathleen M. Rhoads
Represented By: Thomas G McIntosh
Represented By: Celeste R Coco-Ewing
Represented By: Jennifer Snyder Heis
Represented By: Daniel Jay Gerber
Represented By: Tracy J. Van Steenburgh
Represented By: Laura E DeSantos
Represented By: Timothy Gage Harvey
Represented By: Ellison F Hitt
Represented By: Rex A Littrell
Represented By: Allison L. Jones
Represented By: Mary Lynn Tate
Represented By: Kelly Marie Lippincott
Represented By: Brian Rubenstein
Represented By: George F Verschelden
Represented By: David A Landman
Represented By: Timothy L. Warnock
Represented By: Frederick M. Erny
Represented By: Lisa Marlo Kuhnell
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: The Cooper Companies, Inc.
Represented By: Jeffrey Francis Peck
Represented By: W Patrick Sullivan
Represented By: Barry S. Cobb
Represented By: Tracy H. Fowler
Represented By: Kathleen M. Rhoads
Represented By: Thomas G McIntosh
Represented By: Celeste R Coco-Ewing
Represented By: Jennifer Snyder Heis
Represented By: Daniel Jay Gerber
Represented By: Tracy J. Van Steenburgh
Represented By: Frederick M. Erny
Represented By: Laura E DeSantos
Represented By: Timothy Gage Harvey
Represented By: Ellison F Hitt
Represented By: Rex A Littrell
Represented By: Allison L. Jones
Represented By: Mary Lynn Tate
Represented By: Kelly Marie Lippincott
Represented By: Brian Rubenstein
Represented By: George F Verschelden
Represented By: David A Landman
Represented By: Timothy L. Warnock
Represented By: Lisa Marlo Kuhnell
Represented By: Celeste R. Coco-Ewing
Represented By: Rex Allen Littrell
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: CooperSurgical, Inc.
Represented By: Jeffrey Francis Peck
Represented By: W Patrick Sullivan
Represented By: Barry S. Cobb
Represented By: Tracy H. Fowler
Represented By: Kathleen M. Rhoads
Represented By: Thomas G McIntosh
Represented By: Celeste R Coco-Ewing
Represented By: Jennifer Snyder Heis
Represented By: Daniel Jay Gerber
Represented By: Tracy J. Van Steenburgh
Represented By: Laura E DeSantos
Represented By: Timothy Gage Harvey
Represented By: Ellison F Hitt
Represented By: Rex A Littrell
Represented By: Allison L. Jones
Represented By: Mary Lynn Tate
Represented By: Kelly Marie Lippincott
Represented By: Brian Rubenstein
Represented By: George F Verschelden
Represented By: David A Landman
Represented By: Timothy L. Warnock
Represented By: Frederick M. Erny
Represented By: Lisa Marlo Kuhnell
Represented By: Celeste R. Coco-Ewing
Represented By: Rex Allen Littrell
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Women's Health, LLC doing business as Teva Women's Health LLC
Represented By: Frederick M. Erny
Represented By: Kelly Marie Lippincott
Represented By: Mary Lynn Tate
Represented By: Rex Allen Littrell
Represented By: Thomas G McIntosh
Represented By: Barry S. Cobb
Represented By: Ellison F Hitt
Represented By: Timothy L. Warnock
Represented By: Tracy J. Van Steenburgh
Represented By: Kathleen M. Rhoads
Represented By: Laura E DeSantos
Represented By: Brian Rubenstein
Represented By: Daniel Jay Gerber
Represented By: David A Landman
Represented By: Tracy H. Fowler
Represented By: Allison L. Jones
Represented By: Celeste R. Coco-Ewing
Represented By: George F Verschelden
Represented By: Lisa Marlo Kuhnell
Represented By: Timothy Gage Harvey
Represented By: W Patrick Sullivan
Represented By: Jennifer Snyder Heis
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Women's Health LLC
Represented By: George F Verschelden
Represented By: Kelly Marie Lippincott
Represented By: Rex Allen Littrell
Represented By: Thomas G McIntosh
Represented By: Brian Rubenstein
Represented By: Daniel Jay Gerber
Represented By: Allison L. Jones
Represented By: Barry S. Cobb
Represented By: Celeste R. Coco-Ewing
Represented By: Ellison F Hitt
Represented By: Frederick M. Erny
Represented By: Mary Lynn Tate
Represented By: Timothy Gage Harvey
Represented By: Tracy H. Fowler
Represented By: Jennifer Snyder Heis
Represented By: David A Landman
Represented By: Tracy J. Van Steenburgh
Represented By: Laura E DeSantos
Represented By: Timothy L. Warnock
Represented By: Kathleen M. Rhoads
Represented By: Lisa Marlo Kuhnell
Represented By: W Patrick Sullivan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Branded Pharmaceutical Products R&D, Inc.
Represented By: Frederick M. Erny
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?